Dsru: See Their Revenue, Competitors, Traffic, and Reviews (September 2024)

Review (September 2024)

10.7M

Estimated Revenue

83.36k

Website Visitors

4/5

Trustpilot Score

What do we know about Drug Safety Research Unit?

Estimated Revenue (2020)

$10.7M

Total Employees

40 Industry

Pharmaceuticals

Location

Bursledon, United Kingdom

About

Drug Safety Research Unit: DSRU is an independent academic unit internationally respected for its work in Pharmacovigilance, Pharmacoepidemiology, Risk Management and Training Services.

Social Links

What is Drug Safety Research Unit's Revenue?

Drug Safety Research Unit's estimated revenue for 2023 is $10.7M.

What does Drug Safety Research Unit do?

Aim Our aim is to achieve the highest possible scientific and ethical standards, by putting the interests of patients first and to work with integrity and fairness with all our partners. Risk management Through our historical links with doctors in the NHS, the unit conducts studies in both primary and secondary care, many of which are risk management studies which are part of Risk Management Plans (RMPs) in the EU. Pharmacovigilance Our activities are principally concerned with pharmacovigilance, that is, the detection of side-effects associated with the use of marketed drugs. The DSRU undertakes all forms of research studies and evaluations of the safety of medicines and provides education and training in pharmacovigilance and related subjects. Independent Scientific Excellence The DSRU is an independent unit providing scientific excellence demonstrated through conducting studies which are used to support public health decisions and production of publications in international peer reviewed journals since 1980. The DSRU makes significant, valuable contributions in the area of post marketing surveillance of pharmaceutical products. We have achieved both recognition and endorsement by the regulatory authorities, healthcare professionals and pharmaceutical industry worldwide. Experts in Pharmacovigilance Education The DSRU have been providing pharmacovigilance training in the UK since 2000, to fulfil the requirements of professionals from around the world in pharmacovigilance. We are one of the leading providers of pharmacovigilance training in Europe. Our portfolio of short courses, conferences and postgraduate programmes in pharmacovigilance are supported by a broad range International companies. Our practical expertise in pharmacovigilance makes us Experts in Pharmacovigilance Education.

What are the monthly traffic metrics for Dsru?

6/mo Traffic Growth

16.20%

All Time Traffic Growth

Create Free Account

Monthly Hits

83k

Time on Site

3.1Mins

Bounce Rate

46%

How fast is Dsru growing?

Dsru has grown by 1298.0% in the last 6 months according to SimilarWeb.

How do people interact with Dsru?

Last month, Dsru received 83k visitors who spent an average of 3.1 minutes on the website and visited 3.0 different pages per session. Overall, 46% of people bounce on the first visit.

How do people find Dsru?

32.3k people (39%) visit Dsru directly. 41.3k (50%) people search for them in Google. Whereas, 450.4 (1%) discover Dsru through Facebook, Reddit, and YouTube. 925.9 (1%) visitors come from Dsru's email newsletters. Finally, 18.9 (0.0%) people come from affiliates and or paid referrals.

Who uses Dsru?

Dsru's top market is the United States and they receive 45.4k (54.5%) people.
Then the 2nd is Canada with 5.8k (6.9%).
The 3rd is is Brazil with 4.9k (5.9%).

Traffic Growth (last 6 months)

All Traffic Source

Country Share

Traffic Growth (last 12 months)

See 12/mo Traffic Stats

Clickup

Our mission is to make the world more productive. to do this, we built one app to replace them all - tasks, docs, goals, and chat.... More